Sign In
Buy PRGO
$9.60
-0.650 (-6.34%)
At Close: Jun 22, 2026
Why Is Perrigo (PRGO) Down 15.1% Since Last Earnings Report?
12:35pm, Thursday, 06'th Jun 2024
Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock?
Perrigo to Attend Oppenheimer 24th Annual Consumer Growth & E-Commerce Conference
08:03am, Tuesday, 28'th May 2024
DUBLIN , May 28, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduard
Understanding Perrigo (PRGO) Reliance on International Revenue
12:56pm, Monday, 13'th May 2024
Explore how Perrigo's (PRGO) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Perrigo (PRGO) Q1 Earnings Surpass, Sales Miss Estimates
12:26pm, Tuesday, 07'th May 2024
Perrigo (PRGO) reports mixed first-quarter 2024 results. Management reiterates its financial outlook for 2024.
Perrigo (PRGO) Reports Q1 Earnings: What Key Metrics Have to Say
10:36am, Tuesday, 07'th May 2024
The headline numbers for Perrigo (PRGO) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimate
Perrigo Reports First Quarter 2024 Financial Results From Continuing Operations
06:31am, Tuesday, 07'th May 2024
Delivered Adjusted Diluted Earnings Per Share Results Above Projection, Due Primarily to Timing of Infant Formula Shipments; Reaffirm 2024 Financial Outlook Advanced Augmenting and Strengthening of In
Perrigo Announces Executive Transition for its Consumer Self-Care International (CSCI) Business
06:28am, Tuesday, 07'th May 2024
Svend Andersen, EVP and President Consumer Self-Care International (CSCI), to Retire Roberto Khoury, a Global Branded Consumer Health Veteran, Appointed to Lead the Business DUBLIN , May 7, 2024 /PRNe
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
11:41am, Monday, 06'th May 2024
Let us look at five drug, generic companies, PRGO, IOVA, VTRS, TEVA and ACAD, which are gearing up for their earnings release this week.
Insights Into Perrigo (PRGO) Q1: Wall Street Projections for Key Metrics
10:21am, Monday, 06'th May 2024
Besides Wall Street's top -and-bottom-line estimates for Perrigo (PRGO), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qu
Perrigo Announces Quarterly Dividend
09:42am, Wednesday, 01'st May 2024
DUBLIN , May 1, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly divid
Perrigo (PRGO) to Report Q1 Earnings: Here's What to Expect
12:01pm, Tuesday, 30'th Apr 2024
Perrigo's (PRGO) new products and products added through acquisitions are expected to have aided the top line in the soon-to-be-reported quarter.
Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million
06:00am, Thursday, 25'th Apr 2024
Proposed Divestment of Branded Prescription Pharma Business Further Supports Perrigo's Strategic Focus on Consumer Self-Care Total Purchase Consideration of up to €275 Million, Consisting of €190
Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024
08:09am, Tuesday, 23'rd Apr 2024
DUBLIN , April 23, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its first quarter 2024 financial res
Upcoming Catalysts Position Perrigo For Sustained Long-Term Dividend Growth
05:49am, Tuesday, 09'th Apr 2024
After nearly a decade of struggles, Perrigo is poised to turn the corner under the leadership of a new CEO who is only nine months in the seat. Infant formula woes will be resolved in Q2 and compariso
CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors
04:59pm, Thursday, 04'th Apr 2024
CVS Caremark, the pharmacy benefit management subsidiary of CVS Health Corp , will add Perrigo's birth control pill to its preventive services oral contraceptives list and make it available at no cost
